Korean J Dermatol.
2004 Jun;42(6):728-734.
Insulin-like Growth Factor-II (IGF-II) Induces Vascular Endothelial Growth Factor (VEGF) Expression through IGFR-1 and ERK1/2 Activation in Psoriasis
- Affiliations
-
- 1Laboratory of Immunopathology, Natonal Institute of Allergy and Infectious Diseases, National Institute of Health, Maryland, USA.
- 2College of Pharmacy, Seoul National University, Seoul, Korea.
- 3Department of Dermatology, College of Medicine, Pusan National University, Busan, Korea. kwonks@pusan.ac.kr
Abstract
- BACKGROUND
Psoriasis is a chronic relapsing and angiogenic skin disease characterized by variable clinical features. But the pathogenetic process resulting in vascular morphological changes remains to be proven. It is reported that the potent angiogenic factor VEGF is overexpressed in psoriatic epidermis and the level of IGF-II is significantly elevated in tissue fluid and serum of the psoriatic lesion. OBJECTIVE AND METHOD: To find the mechanism of VEGF induction in pathogenesis of psoriasis, we adopt IGF-II as a paracrine inducer of VEGF in psoriasis. To investigate the signaling pathway of IGF-II-induced VEGF, we determined ERK1/2 activity in IGF-II-treated psoriatic cells. RESULT: In this report, we demonstrated that IGF-II induced the expression of VEGF in lesional keratinocytes of psoriasis. And IGF-II stimulated the expression of its receptor, IGFR-I in psoriatic cells. Treatment of anti-IGFR-I neutralizing antibody diminished VEGF mRNA level induced by IGF-II, indicating that VEGF induction by IGF-II may be mediated through IGFR-I. By the treatment of PD98059, specific inhibitor of upstream ERK activator MAP kinase/ERK kinase (MEK), the expression of VEGF induced by IGF-II was dramatically reduced. CONCLUSION: Taken together, these results suggest that IGF-II might regulate angiogenesis by the induction of VEGF through the MAP kinase pathway mediated by IGFR-I in the lesion of psoriasis.
MeSH Terms
-
Angiogenesis Inducing Agents
Antibodies, Neutralizing
Epidermis
Insulin-Like Growth Factor II
Keratinocytes
Phosphotransferases
Psoriasis*
RNA, Messenger
Skin Diseases
Vascular Endothelial Growth Factor A*
Angiogenesis Inducing Agents
Antibodies, Neutralizing
Insulin-Like Growth Factor II
Phosphotransferases
RNA, Messenger
Vascular Endothelial Growth Factor A
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Alteration of Growth Factor Expression after Acute Ischemic Renal Injury
- the effects of insulin-like growth factor i (igf-i) on expression of vascular endothelial growth factor (vegf) mrna in mg-63 osteoblastlike cells
- Insulin-like growth factor-I and II and insulin-like growth factor binding protein-3 in amniotic fluid at second trimester: A correlation with birth weight
- A Case of non-islet Cell Tumor Hypoglycemia Due to Gepatoma-increased serum subfraction of big insulin-like growth factor II
- Expression of insulin-like growth factor [IGF] -Ia , IGF-Ib , and IGF-II messenger ribonucleic acid in uterine leiomyoma
